patient data

This study investigates the additional impact of Leap Motion-based VR therapy, when used alongside conventional treatment, on the upper extremity function, physical activity and participation of stroke patients. Forty post-stroke patients were randomly assigned to either a control (CG) or an experimental group (EG). Both groups received 60 minutes of CT, while the EG received additional 40 minutes of VR therapy, five days a week for four weeks. Outcome measures included the Fugl-Meyer Assessment for Upper Extremity (FMA-UE), Selective Control of the Upper Extremity Scale (SCUES), Nine-Hole Peg Test (NHPT), Disabilities of the Arm, Shoulder and Hand questionnaire (DASH-T), and Stroke-Specific Quality of Life Scale (SS-QOL). Outcome assessments were performed by an independent assessor at baseline (T0), post-intervention (4 weeks,T1), and at 1 (T2)- and 3 (T3)-month follow-ups. Patient demographic data and assessment results for each time period are presented individually in Excel.